Generali Investments CEE’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Generali Investments CEE's MRNA Position: Q2 2026 in Review
Generali Investments CEE held its Moderna (MRNA) position steady in Q2 2026 at 12,700 shares worth $889K. The position accounts for 0.04% of the portfolio, ranked #304.
Generali Investments CEE first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Generali Investments CEE held 12,700 shares of Moderna worth $889K as of Q2 2026.
- Generali Investments CEE left its Moderna share count unchanged in Q2 2026.
- Moderna made up 0.04% of Generali Investments CEE's portfolio in Q2 2026, its #304 holding.
- Generali Investments CEE first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
- 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.